Mechanism of PTEN deficient breast cancer detailed, suggesting improved therapeutics

by

A group of researchers led by the Dana-Farber Cancer Institute, Boston, has illustrated the mechanistic pathway for PTEN-deficient breast cancer and successfully tested a method of countering the downstream effects of immune system evasion by tumors.

Leave A Comment

Your email address will not be published. Required fields are marked *